血红素加氧酶-1启动子区多态性与疾病易感性的关系

摘要/Abstract

摘要： 血红加氧酶-1(HO-1)是一种诱导性抗氧化防御酶,可分解血红素释放出游离铁、一氧化碳和胆绿素,后者可迅速转化为胆红素,这三种代谢产物具有抗炎、抗氧化、抗增殖的作用。HO-1在大多数组织内呈低水平表达,可被多种伤害性刺激诱导产生高水平表达,从而在维持细胞内稳态方面起着重要作用。最近研究表明其基因启动子区5′端区域的2个突变可影响其转录水平,并且与多种疾病的发生发展密切相关,本文就此2个位点的多态性对HO-1的功能及其临床方面的意义作一综述。

关键词: 血红加氧酶-1, 氧化应激, 稳态, 启动子, 突变

Abstract: Heme oxygenase-1(HO-1), the inducible isoform of heme oxygenase, is a cytoprotective enzyme that plays a central role in the defense against oxidative. HO-1 catalyzes the degradation of heme into iron, carbon monoxide (CO), and biliverdin, which is quickly converted into bilirubin. These downstream products of heme catabolism have recently been found to be some protective factors with potent anti-inflammatory, anti-oxidant, and anti-proliferative effects. Although HO-1 is expressed in various tissues at a low level, and is upregulated by multiple adverse stimuli, thus it plays an important role in keeping cell redox homeostasia under various pathophysiological conditions. From several studies it seems that two potentially function polymorphisms in the 5'-flanking region of human HO-1 gene promoter modulate the quantitative level of HO-1 activity, and the polymorphisms were shown to be associated with susceptibility to various disease, so the present article focuses on the role of this two polymorphisms on its function as well as disease susceptibility.

Key words: Heme oxygenase-1, Oxidative stress, Homeostasis, Promoter, Mutation

中图分类号:

R968

侯瑞英, 刘昭前. 血红素加氧酶-1启动子区多态性与疾病易感性的关系[J]. 中国临床药理学与治疗学, 2010, 15(3): 335-341.

HOU Rui-ying, LIU Zhao-qian. Association between heme oxygenase-1 gene promoter polymorphism and the susceptibility of human disease[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(3): 335-341.

参考文献

[1] Fredenburgh LE, Perrella MA, MitsialisSA,et al. The role of heme oxygenase-1 in pulmonary di-sease[J]. Am J Respir Cell Mol Biol,2007,36(2):158-165.
[2] Stocker R, Perrella MA. Heme oxygenase-1: a novel drug target for atherosclerotic diseases[J]? Circulation,2006,114(20):2178-2189.
[3] Vitek L, Malikova I, Kvasnicka J,et al. Relationship between serum bilirubin and markers of infl-ammation and oxidative stress[J]. Gastroenterol Hepatol,2007, 22 (2):235-240.
[4] Morita T. Heme oxygenase and atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2005,25(9):1786-1795.
[5] Ganotakis ES,Vrentzos GE,Gazi IF, et al. Fibrinogen, lipoprotein (a),albumin and bilirubin (F-L-A-B) and cardiovascular risk calculated using the Framingham equation[J]. In Vivo, 2007,21 (4):685-694.
[6] Heo JM,Kim HJ,Ha YM,et al. YS 51,1-(beta-naphtylmethy1)-6,7-dihydroxy-1,2,3,4,-tetrahydr-oisoquinoline, protects endothelial cells against hydrogen peroxide-induced injury via carbon monoxide derived from heme oxygenase-1[J]. Biochem Pharmacol, 2007,74(9):1361-1370.
[7] Althaus M,Fronius M, Buchäckert Y, et al. Carbon monoxide rapidly impairs alveolar fluid clearance by inhibiting epithelial sodium channels[J]. Am J Respir Cell Mol Biol, 2009,41(6):639-650.
[8] Greoire IP, Correia AM, Soaxes MP, et al. Heme oxygenase-1 derived carbon monoxide inhibits atherosclerosis[J]. Atherosclerosis Supplements, 2006,7(3):198.
[9] Bye A, Sorhaug S, CeciM, et al. Carbon monoxide levels experienced by heavy smokers impair aerobic capacity and cardiac contractility and induce pathological hypertrophy[J]. Inhal Toxicol, 2008,20(7):635-646.
[10]LiW, Xu LH, Forssel C, et al. Over expression of transferring receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques[J]. Exp Biol Med, 2008,233(7):818-826.
[11]Immenschrh S, Schroder H. Heme oxygenase-1 and cardiovascular disease[J]. Histol Histopathol, 2006,21(6):679-685.
[12]Hirai H, Kubo H, Yamaya M, et al. Microsatellite polymorphism in heme oxygenase-1 gene pro-moter is associatedwith susceptibility to oxidant-induced apoptosis in lympho blastoid cell lines[J]. Blood, 2003,102(5):1619-1624.
[13]Chora AA, Fontoura P, Cunha A, et al. Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation[J]. Clin Invest, 2007,2(117): 438-447.
[14]Exner M, Minar E, Wagner O, et al. The role of heme oxygenase-1 promoter polymorphisms in human disease[J]. Free Radic Biol Med, 2004,37(8):1097-1104.
[15]Yamada N, Yamaya M, Okinaga S, et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema[J]. Hum Genet, 2000,66(1):187-195.
[16]Ono K, Mannami T, Iwai N. Association of a promoter variant of the haem oxygenase-1 gene with hypertension in women[J]. Hypertens,2003,21(8):1497-1503.
[17]Ono K, Goto Y, Takagi S, et al. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese[J]. Atherosclerosis,2004,173(2):313-317.
[18]Li YG, Wang DM, Chen SM, et al. Haem oxygenase-1 expression and coronary heart disease-as-sociation between levels of haem oxygenase-1 expression and angiographic morphology as well as the quantity of coronary lesions[J]. Acta Cardiol, 2006,61(3):295-300.
[19]Chen SM, Li YG, Wang DM. Study on changes of heme oxygenase-1 expression in patients wit-h coronary heart disease[J]. Clin Cardiol, 2005,28(4):197-201.
[20]Chen YH, Lin SJ, Lin MW, et al. Microsatellite polymorphism in promoter of heme oxygenase gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients[J]. Hum Genet, 2002, 111(1):1-8.
[21]Dick P, Schillinger M, Minar E, et al. Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease[J]. Eur J Clin Invest, 2005,35(12):731-737.
[22]Kaneda H, Ohno M, Taguchi J, et al. Heme oxygenase-1 gene promoter polymorphism is asso-ciated with coronary artery disease in Japanese patients with coronary risk factors[J]. Arterioscler Thromb Vasc Biol, 2002,22(10):1680-1685.
[23]Lublinghoff N,Winkler K,Winkelmann BR,et al.Genetic variants of the promoter of the heme oxygenase-1 gene and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study)[J]. BMC Med Genet, 2009,10(1):36.
[24]Schillinger M, Exner M, Minar E, et al. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor[J]. Am Coll ardiol, 2004,43(6):950-957.
[25]Chen YH, Chau LY, Lin MW, et al. Heme oxygenase-1 gene promotor microsatellite polymerp-hism is associated with angiographic restenosis after coronary stenting[J]. Eur Heart J, 2004,25(1):39-47.
[26]Exner M, Schillinger M, Minar E, et al. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty[J]. Endov-asc Ther, 2001,8(5):433-440.
[27]Schillinger M, Exner M,Mlekusch W, et al. Heme oxygenase-1 gene promoter polymerphism is associated with abdominal aortic aneurysm[J]. Thromb Res, 2002,106(2):131-136.
[28]Mustafa S, Weltermann A, Marsik C, et al.Genetic variation in heme oxygenase 1(HMOX1) and the risk of recurrent venous thromboembolism[J]. J Vasc Surg, 2008,47(3):566-570.
[29]Yamada N, Yamaya M, Okinaga S, et al. Microsatellite polymophism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphsema[J]. Hum Genet, 2000,66(1):187-195.
[30]Budhi A, Hiyama K, Isobe T,et al. Genetic susceptibility for emphysematons changes of the lung in Japanese[J]. Int J Mol Med, 2003,11(3):321-329.
[31]Fu WP,Zhao ZH, Fang LZ,et al.Heme oxygenase-1 polymorphism associated with severity of chronic obstructive pulmonary disease[J]. Chin Med J, 2007,120(1):12-16.
[32]Kikuchi A, Yamaya M, Suzuki S, et al. Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism[J]. Hum Genet, 2005,166(5):354-360.
[33]Yasuda H, Okinaga S, Yamaya M,et al. Association of susceptibility to the development of pneumonia in the older Japanese population with haem oxygenase-1 gene promoter polymorphism[J]. J Med Genet, 2006,43(4):e17.
[34]Islam T, McConnell R, Gauderman WJ,et al. Ozone, oxidant defense genes, and risk of asthma during adolescence[J]. Am J Respir Crit Care Med, 2008,177(4):388-395.
[35]Lagan AL, Quinlan GJ,Evans TW,et al.Haem oxygenase-1 polymorphism and ARDS, friend and foe[J]? Intensive Care Med, 2009,35(8):1325-1327.
[36]Hersh CP, DeMeo DL, Lange C,et al. Attempted replication of reported chronic obstructive pul-monary disease candidate gene associations[J]. Am J Respir Cell Mol Biol, 2005,33(1):71-78.
[37]He JQ, Ruan J, Connett JE, et al. Antioxidant gene polymorphisms and susceptibility to rapid decline in lung function in smokers[J]. Am J Respir Crit Care Med, 2002,166(3):323-328.
[38]Geuken E,Buis CI,Vsser DS,et al. Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation[J]. Am J Transplant, 2005,5(8):1875-1885.
[39]Exner M, Bohmig GA, Schillinger M,et al. Donor heme oxygenase-1 genotype is associated with renal allograft function[J]. Transplantation, 2004,77(4):538-542.
[40]Buis CI,vander Steege G, Visser DS,et al. Heme oxygenase-1 genotype of the donor is associated with graft survival after liver transplantation[J]. Am J Transplant, 2008,8(2):377-385.
[41]Chang KW,Lee TC,Yeh WI,et al. Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers[J]. Br J Cancer, 2004,91(8):1551-1555.
[42]Okamoto I,Krogler J, Endler G, et al.A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma[J]. Int J Cancer, 2006,119(6):312-1315.
[43]Sawa T, Mounawar M, Tatemichi M,et al.Increased risk of gastric cancer in Japanese subjects is associated with microsatellite polymorphisms in the heme oxygenase-1 and the inducible nitric oxide synthase gene promoters[J]. Cancer Lett, 2008,269(1):78-84.
[44]Lo SS,Lin SC,Wu CW,et al.Heme Oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion[J]. Am J Surg, 2007,17(8):2250-2256.
[45]Conrad B,Gero V,Mathias S,et al. limits of an optimal correcion of renal anemia in hemodialysis patients[J]. Blood Purif, 2009,28(4):327.
[46]Wagener FADTG,Toonen EJM,Wigman L,et al.HMOX1 promoter polymorphism modulates the relationship between disease activity and joint damage in rheumatoid arthritis[J]. Arthritis Rheum,2008,58(11):3388-3393.